Inmune Bio, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Inmune Bio, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Inmune Bio, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 20.2M shares, a 12.1% increase year-over-year.
  • Inmune Bio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 18M shares, a 0.3% increase from 2022.
  • Inmune Bio, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 17.9M shares, a 11.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 20.2M +2.18M +12.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 19.3M +1.36M +7.59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 18M +80.5K +0.45% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 18M +53.5K +0.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 18M +62.3K +0.35% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 17.9M 0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 17.9M +75.7K +0.42% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 17.9M +1.8M +11.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 17.9M +617K +3.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 17.9M +2.97M +19.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 17.9M +3.55M +24.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 16.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 17.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 15M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 14.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.